Dermata Therapeutics Inc (DRMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Operating Expenses | 2,262 | 492 | 540 | 793 | 1,349 |
| Operating Income | -2,262 | -492 | -540 | -793 | -1,349 |
| Interest Expense | 43 | 39 | 57 | 29 | 73 |
| Other Income | 0 | 133 | 0 | 0 | 0 |
| Pre-tax Income | -2,305 | -397 | -597 | -822 | -1,421 |
| Net Income Continuous | -2,305 | -397 | -597 | -822 | -1,421 |
| Net Income | $-2,305 | $-397 | $-597 | $-822 | $-1,421 |
| EPS Basic Total Ops | -2,902.55 | -503.75 | -743.63 | -1,031.48 | -1,775.11 |
| EPS Basic Continuous Ops | -2,893.26 | -497.47 | -749.88 | -1,031.38 | -1,783.93 |
| EPS Diluted Total Ops | -2,902.55 | -503.75 | -743.63 | -1,031.48 | -1,775.11 |
| EPS Diluted Continuous Ops | -2,893.26 | -497.47 | -749.88 | -1,031.38 | -1,783.93 |
| EBITDA(a) | $-2,248 | $-483 | $-524 | $-778 | $-1,291 |